1. Multifunctional nanoparticle-mediated combining therapy for human diseases
   Xiaotong Li et al, 2024, Signal Transduction and Targeted Therapy CrossRef
2. Refractory Thyroid Eye Disease Unresponsive to Teprotumumab: A Case Report
   Gurdeep Singh et al, 2023, Cureus CrossRef
3. Potential role of IGF-1R in the interaction between orbital fibroblasts and B lymphocytes: an implication for B lymphocyte depletion in the active inflammatory phase of thyroid-associated ophthalmopathy
   Renyan Wang et al, 2024, BMC Immunology CrossRef
4. Correlation between extraocular muscle enlargement and thyroid autoantibodies in thyroid eye disease
   Takahiro Koizumi et al, 2024, Japanese Journal of Ophthalmology CrossRef
5. Euthyroid graves’ ophthalmopathy in a Chinese population: A cross-sectional follow-up study
   Kenneth KH Lai et al, 2024, European Journal of Ophthalmology CrossRef
6. Macular microvasculature in patients with thyroid-associated orbitopathy: a cross-sectional study
   Mojtaba Abrishami et al, 2023, Thyroid Research CrossRef
7. Ocular surface and meibomian gland evaluation in euthyroid Graves’ ophthalmopathy
   Kenneth Ka Hei Lai et al, 2024, International Ophthalmology CrossRef